Afya Limited (BVMF:A2FY34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 5.03B -27.9% |
| Revenue (ttm) | 3.83B +7.9% |
| Net Income | 782.27M +12.7% |
| EPS | 4.59 +16.8% |
| Shares Out | n/a |
| PE Ratio | 6.20 |
| Forward PE | 5.74 |
| Dividend | 1.64 (5.75%) |
| Ex-Dividend Date | Mar 24, 2026 |
| Volume | 3,003 |
| Open | 28.47 |
| Previous Close | 28.47 |
| Day's Range | 28.47 - 28.47 |
| 52-Week Range | 24.25 - 43.40 |
| Beta | 0.43 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 12, 2026 |
About Afya Limited
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering... [Read more]
Financial Performance
In 2025, Afya Limited's revenue was 3.70 billion, an increase of 11.89% compared to the previous year's 3.30 billion. Earnings were 752.46 million, an increase of 19.15%.
Financial StatementsNews
Afya upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley last night upgraded Afya (AFYA) to Equal Weight from Underweight with a price target of $12.60, down from $15. The firm remains cautious on the company’s seat maturation…
Afya upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley analyst Mauricio Cepeda upgraded Afya (AFYA) to Equal Weight from Underweight with a $12.60 price target
Afya price target lowered to $17.50 from $19 at JPMorgan
JPMorgan analyst Marcelo Santos lowered the firm’s price target on Afya (AFYA) to $17.50 from $19 and keeps an Overweight rating on the shares. The firm updated estimates in the…
Afya upgraded to Buy at Citi amid ‘resilient undergraduate trends’
As previously reported, Citi upgraded Afya (AFYA) to Buy from Neutral with a price target of $12, down from $16. The firm expects the company to report a good quarter…
Afya upgraded to Buy from Neutral at Citi
Citi upgraded Afya (AFYA) to Buy from Neutral with a price target of $12, down from $16.
BofA upgrades Afya to Buy after ‘exaggerated’ sellofff
As previously reported, BofA upgraded Afya (AFYA) to Buy from Neutral with a price target of $16, down from $19. The recent selloff was “exaggerated” considering Afya’s exposure to a…
Afya upgraded to Buy from Neutral at BofA
BofA analyst Flavio Yoshida upgraded Afya (AFYA) to Buy from Neutral with a price target of $16, down from $19.
Afya Limited Transcript: Investor Day 2026
The strategy pairs a mature medical education core with digital monetization and broader growth avenues. The proposed Yduqs combination targets BRL 2.2bn in synergies, subject to approvals and disciplined integration.
Afya Limited Slides: FY 2026
Afya Limited has posted slides in relation to its FY 2026 quarterly earnings report, which was published on October 20, 2026.
Afya upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Marcelo Santos upgraded Afya (AFYA) to Overweight from Neutral with a price target of $19, down from $21. The firm is constructive on the company’s merger with Yduqs.
Merger Agreement and Other Covenants Entered Into by and Between AFYA LIMITED and YDUQS PARTICIPAÇÕES S.A.
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34): Dated September 23, 2026 MERGER AGREEMENT AND OTHER COVENANTS This Merger Agreement and Other Covenants (“Agreement”),...
Afya Limited and YDUQS Participações S.A. Controlling Shareholders Enter Into Voting Commitment Agreement
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34): VOTING COMMITMENT AGREEMENT entered into by and among As Parties ROSE FUNDO DE INVESTIMENTO EM PARTICIPAÇÕES MULTIESTR...
Afya Limited to Host Afya Day 2026 on October 20th in Rio de Janeiro
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today...
Afya upgraded to Outperform from Underperform at Bradesco BBI
Bradesco BBI upgraded Afya (AFYA) to Outperform from Underperform with a $17 price target
Afya Limited Transcript: M&A announcement
The merger will create Brazil's largest higher education platform, combining complementary brands and nationwide reach, with significant synergies estimated at BRL 2–2.2 billion and a strong focus on premium and medical education. The deal offers a 45% premium and substantial dividends, pending regulatory and shareholder approvals.
Afya Limited Press release: M&A announcement
Afya Limited issued a press release on September 24, 2026, disclosing material business information to investors.
Afya Limited Slides: M&A announcement
Afya Limited has posted slides in relation to its latest quarterly earnings report, which was published on September 24, 2026.
Afya Limited and Yduqs Participações S.A. Enter Into Merger Agreement
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), announced today that it has entered into a binding merger agreement with Yduqs Participações...
Afya announces medical seats increase in AFYA Cruzeiro de Sul
Afya (AFYA) announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education authorized the increase of 17 medical seats of ITPAC Cruzeiro do Sul…
Afya Limited Announces Medical Seats Increase in AFYA Cruzeiro do Sul
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today...
Afya comments on disclosure by Yduqs regarding potential business combination
Afya (AFYA) Limited announced that discussions with Yduqs Participacoes regarding a potential business combination involving the two companies are at an early stage, following the material fact disclo...
Afya Limited Comments on Recent Public Disclosure Made by Yduqs Participações S.A. Regarding a Potential Business Combination
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that discussions with Yduqs Participações S.A. (B3: YDUQ3) ("Yduqs") regarding a potential business comb...
Afya reports Q2 EPS R$2.22 vs. R$1.90 last year
Reports Q2 revenue R$972.1M vs. $919.4M last year. Q2 revenue excluding acquisitions increased 5.4% to R$969.3M. Afya (AFYA) management commented, “During the first half of 2026, Afya continued to exe...
Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, repor...
Afya Limited Earnings Call Transcript: Q2 2026
Revenue grew 7% and net income rose 7% year-over-year in the first half of 2026, with strong cash generation and disciplined capital allocation leading to over 100% of Free Cash Flow to Equity returned to shareholders. Competitive and regulatory factors impacted some segments, but guidance remains unchanged.